Format

Send to

Choose Destination
Future Oncol. 2012 Sep;8(9):1135-47. doi: 10.2217/fon.12.112.

The changing landscape of therapeutic strategies for recurrent ovarian cancer.

Author information

1
University Hospital of Giessen & Marburg, Marburg Site, Germany. baumannk@med.uni-marburg.de

Abstract

Advanced epithelial ovarian cancer, cancer of the fallopian tube and primary peritoneal cancer have a poor prognosis and a high rate of disease recurrence following primary therapy. Recurrent ovarian cancer is currently classified according to sensitivity to platinum-based chemotherapy. Data on targeted therapy provide evidence of improvement with systemic treatment in addition to chemotherapy. Other strategies, although not proven in randomized trials, offer interesting options for future research and therapeutic development. In this review, the covered treatment modalities include surgery, chemotherapy and targeted therapy, immunological approaches and irradiation.

PMID:
23030488
DOI:
10.2217/fon.12.112
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center